A literature review of radio-genomics in breast cancer: Lessons and insights for low and middle-income countries [0.03%]
乳腺癌放射组学的文献综述:对中低收入国家的经验和启示
Mehwish Mooghal,Kulsoom Shaikh,Hafsa Shaikh et al.
Mehwish Mooghal et al.
To improve precision medicine in breast cancer (BC) decision-making, radio-genomics is an emerging branch of artificial intelligence (AI) that links cancer characteristics assessed radiologically with the histopathology and genomic properti...
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients [0.03%]
非小细胞肺癌分子靶向治疗的生物标志物检测实施
Daniele Lorenzini,Gabriella Gaudioso,Alessandro Scardoni et al.
Daniele Lorenzini et al.
Background: Recent advancements in identifying druggable molecular drivers in lung adenocarcinoma (LUAD), have transformed treatment paradigms. In recent years, Next Generation Sequencing (NGS) has gained momentum as an e...
Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization [0.03%]
基于NGS的HER2拷贝数变异评估的有效性:与免疫组化和原位杂交分析的比较研究
Daniele Lorenzini,Rebecca Salvatori,Chiara Costanza Volpi et al.
Daniele Lorenzini et al.
Introduction: Anti-HER2 drugs are becoming an important therapeutic option for various solid tumors, increasing the need for HER2 status testing. Comprehensive genomic profiling (CGP) panels, including FoundationOne®CDx,...
Effect of the IDH1 inhibitor combined with hypomethylating agents on acute myeloid leukemia [0.03%]
IDH1抑制剂联合低甲基化药物对急性髓系白血病的作用机制研究
Yan Cheng,Hongwei Wu
Yan Cheng
Objective: Mutations in the gene encoding isocitrate dehydrogenase 1 (IDH1) occur in approximately 6-10% of acute myeloid leukemia (AML) patients. Ivosidenib (IVO) is a small-molecule inhibitor of mutant IDH1. This study ...
Engagement in cancer clinical trials among a nationally representative cancer survivor sample: Motivators, barriers and opportunities for improvement [0.03%]
美国全国肿瘤幸存者样本的癌症临床试验参与情况:动机、障碍及改善机会
Zachary S Feuer,Richard S Matulewicz,Ramsankar Basak et al.
Zachary S Feuer et al.
Purpose: Most patients with cancer do not participate in a clinical trial. Understanding clinical participation rates, and the barriers and motivators that influence participation may help identify opportunities for impro...
Clinicopathological characteristics and prognosis of cervical adenocarcinoma across diverse histological subtypes [0.03%]
不同组织学亚型宫颈腺癌的临床病理特征及预后
Xiaowan Guo,Miao Wang,Sisi Yan et al.
Xiaowan Guo et al.
Objective: To investigate the clinical features and prognostic implications of different subtypes of cervical adenocarcinoma. Methods: ...
Adding immune checkpoint inhibitors to chemotherapy in elderly cancer patients: Beneficial for many but not all? [0.03%]
免疫检查点抑制剂联合化疗在老年肿瘤患者中的应用:对许多患者有益但并非人人适用?
Fausto Petrelli,Antonio Ghidini,Italo Sarno et al.
Fausto Petrelli et al.
Introduction: The strategic addition of immune checkpoint inhibitors (ICIs) to chemotherapy (CT) offers a potential paradigm shift in the treatment of elderly cancer patients. This systematic review evaluates the impact o...
Ongoing discussion: Is prophylactic central neck dissection necessary in cT1a-b,2N0 papillary thyroid cancer? [0.03%]
争议不断:cT1a-b,2N0期乳头状甲状腺癌患者需要预防性中央区淋巴结清扫吗?
Ömer Bayır,Latif Akan,Muhammed Kızılgül et al.
Ömer Bayır et al.
Objective: To analyze the central lymph node metastasis (CLNM) rates of patients who underwent prophylactic central lymph node dissection (pCLND) with total thyroidectomy for cT1-2N0 papillary thyroid cancer in our clinic...
Prognostic value of Aurora B expression in cancer patients: A meta-analysis [0.03%]
细胞周期素Aurora B在癌症中的预后价值: meta分析研究
Md Mojahidur Hasan,Sehreen Tory,Yusuf Kemal Arslan et al.
Md Mojahidur Hasan et al.
Background: Overexpression of Aurora B is linked to poor prognosis in various malignancies; however, its prognostic role remains debatable. Conducting a meta-analysis is essential to reach a definitive conclusion.MethodsV...
Association between EGFR mutation types and incidence of brain metastases in postoperative patients with stage I-III NSCLC [0.03%]
EGFR突变类型与I-III期NSCLC术后患者脑转移发生率的关系
Jiexia Zhang,Zhiqiang Luo,Zhiling Xie et al.
Jiexia Zhang et al.
Objective: This retrospective study aims to clarify the association between epidermal growth factor receptor (EGFR) mutation types and brain metastasis incidence in early-stage non-small-cell lung cancer after surgery. ...